skip to content

Cambridge Global Challenges


Applications are invited for Call 1 of the new NIHR Research and Innovation for Global Health Transformation (RIGHT) programme for delivering challenge-led research that will primarily benefit the health and wealth of the poorest individuals living in low and middle income countries (LMICs).

The RIGHT programme forms part of the nation's commitment to Official Development Assistance (ODA) and complements recent investment in NIHR Global Health Research Groups and Units.

RIGHT is a two stage competition, subject to independent peer review and international panel assessment at both stages. 

Key areas

In Call 1, the programme seeks to fund high quality research ideas in three areas of unmet need and underinvestment in LMICs – epilepsy, infection-related cancer and severe stigmatising skin diseases.


Applications are invited from UK-based (England, Wales, Scotland, Northern Ireland) Higher Education Institutions, and research institutes. Non-UK institutions in High-Income Countries can be included in the application if there is a strong justification as to why the expertise they are bringing cannot be found in the UK or in an LMIC. Evidence for this needs to be provided in the application. Applications from joint groupings of UK institutions will be considered, though a lead UK institution must be specified.

Level of funding

The total amount of NIHR funding available for this competition is up to £30 million. Awards will typically range between £3m-5m over 3-4 years for ODA-eligible research to start in June 2019.


For further details please see the NIHR website.

Cambridge Global Challenges is a Strategic Research Initiative of the University of Cambridge that aims to enhance the contribution of its research towards addressing global challenges and achieving the Sustainable Development Goals (SDGs) by 2030.

Funding Opportunities

Find out about open funding opportunities, pre-call announcements, responsive calls, studentships and awards relevant to the global...